-
Assembly Biosciences Stock Jumps After Wall Street Says Gilead Opt-In ‘Significantly De-Risks’ Genital Herpes Programs
22 Dec 2025 23:27 GMT
… Biosciences’ programs for recurrent genital herpes, including investigational candidates ABI- … European countries experience recurrent genital herpes.
Shares of Assembly Biosciences … European countries experience recurrent genital herpes. No new therapies have …
-
Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes
22 Dec 2025 18:55 GMT
… exclusively license Assembly Bio’s herpes simplex virus (HSV) … -5366 for recurrent genital herpes.
These represent the first … &D collaboration. Genital herpes, caused by HSV, is … European countries experience recurrent genital herpes, with HSV type 2 …
-
Scientists’ new gum stops spread of flu and herpes
22 Dec 2025 17:10 GMT
… ; lower viral loads of two herpes simplex viruses and two influenza … .
Flu epidemics occur annually while herpes simplex virus-1 (HSV-1 … called FRIL to neutralize two herpes simplex viruses (HSV-1 and …
-
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
22 Dec 2025 14:16 GMT
… license Assembly Bio’s herpes simplex virus (HSV) … therapy for recurrent genital herpes. Positive interim Phase 1b … primase program for recurrent genital herpes,” said Jason Okazaki, … suffering from recurrent genital herpes.”
Terms of the Transaction …
-
Applying 3D correlative structured illumination microscopy and X-ray tomography to characterise herpes simplex virus-1 morphogenesis
19 Dec 2025 13:49 GMT
Application of correlative cryoSIM and cryoSXT imaging to the study of viral infection has thus far been limited to visualising the entry of reovirus during infection and has not yet been used to study other stages of virus assembly, nor has it been used …
-
WSU finds way to prevent herpes viruses from entering human cells
17 Dec 2025 03:13 GMT
… discovered a way to stop herpes viruses from entering human cells … one amino acid within the herpes virus’s fusion protein that …
-
Dupixent® (Dupilumab) Approved In Japan For Children Aged 6 To 11 Years With Bronchial Asthma
23 Dec 2025 07:08 GMT
… ) in VOYAGE and fever, oral herpes, eosinophilia and injection site reactions … , swelling, itching, and blurred vision, herpes virus infections, common cold symptoms … , itching, and blurred vision, and herpes virus infections.
Tell your healthcare …
-
Press Release: Sanofi And Regeneron's Dupixent Approved In Japan For Children Aged 6 To 11 Years With Bronchial Asthma
23 Dec 2025 07:08 GMT
… ) in VOYAGE and fever, oral herpes, eosinophilia, and injection site reactions …
-
<![CDATA[2025 FDA added indications to dermatologic medications]]>
23 Dec 2025 01:17 GMT
… and lifestyle.”
Vyjuvek is a herpes-simplex virus type 1 vector …
-
Nektar Therapeutics (NKTR) Stock Slides Despite Analyst Optimism On Alopecia Data
22 Dec 2025 21:47 GMT
… Weekly Pill To Tackle Genital Herpes
Image: Shutterstock
This content was …